- Nineteen prisoners use cutlery to break out of cells at Winchester prison
- France wants progress in Ukraine before Russia returns to G7
- Italy president begins talks to seek way out of government crisis
- Italian PM expected to resign as political chaos deepens
- Russia says US cruise missile test ‘regrettable’
- Kremlin - No date set for Normandy talks on Ukraine despite Macron meeting
- Egypt court hands out 6 death sentences on terror charges
- Putin says Russian nuclear explosion poses no threat
- Russian panel eyes alleged foreign interference in protests
- Gran Canaria wildfire triggers evacuation of thousands of people
- PM Johnson calls on Germany and France to compromise on Brexit
- Sudan's ex-president Bashir arrives at corruption trial
TEHRAN, Jan 14- A novel protein could hold the key for slowing or preventing the spread of breast cancer, new research suggests.
TEHRAN, Young Journalists Club (YJC) -A novel protein could hold the key for slowing or preventing the spread of breast cancer, new research suggests.
Researchers at Louisiana State University found Nischarin, a novel protein breast cancer responsible for regulating breast cancer cell migration and movement, works to suppress tumor activity, a study published Friday in the journal Cancer Research.
"This novel role for the tumor suppressor Nischarin not only increases our understanding of the exosome biology, but can be translated to identifying new targets for modulating cancer metastasis," Suresh Alahari, a researcher at LSU Health New Orleans School of Medicine, said in a press release. "Inhibition of the secretion of exosomes may serve as an effective treatment for cancer."
Nischarin release nano-sized Exosomes that consist of proteins and genetic material. Exosomes that come from tumors also have signaling messengers that help along tumor progression and metastasis.
Breast cancer tumor cells with Nischarin release fewer exosomes, lowering the cell's chance of survival. When researchers co-cultured breast cancer cells with exosomes from Nischarin, tumor growth and lung metastasis decreased.
In 2018, breast cancer accounted for 15.3 of all new cancer cases and 6.7 percent of cancer deaths, according to the National Cancer Institute's Surveillance, Epidemiology, and End Results Program. It estimated close to 270,000 new cases of breast cancer in the US and nearly 41,000 deaths from the condition last year.
"It has been shown that exosomes can be developed as carriers for delivering drugs," Alahari said. "Nischarin-expressing exosomes in combination with drugs will likely have very good therapeutic effect on breast cancer patients."
Source: upi
Your Comment